Daphne Zohar

Daphne Zohar is an American entrepreneur. She is the founder and managing partner of PureTech, a R&D company that identifies, invents, and commercializes healthcare focused technology rooted in academic discovery.

In 2003, she was named to the MIT Technology Review TR35 as one of the top innovators in the world under the age of 35.[1] In 2010 she was selected by BioWorld, a widely read biotechnology industry publication, as one of 28 leaders predicted to be the "movers and shakers" of the biotechnology industry over the next twenty years.[2] That same year, Zohar was also featured as one of “The Boston Area’s Top 15 Innovators” by The Boston Globe.[3][4] In 2011, Zohar was named one of Boston Business Journal’s “Women to Watch,”[5] in 2012 she was named one of the most powerful female voices in healthcare innovation and on Twitter by MedCity News,[6] and in 2013, Scott Kirsner of The Boston Globe named Zohar one of the 10 most influential women in biotech.[7]

PureTech and Zohar are also known for development of platform technologies together with strategic partners.[8][9][10][11]

Zohar has also been vocal in criticizing the venture industry for its treatment of entrepreneurs.[12]

References

  1. ↑ "2003 Innovators Under 35". MIT Technology Review. 2003. Retrieved August 15, 2011.
  2. ↑ "The Future is Here: Who Will Shape Biotech Over the Next 20 Years? Bioworld Says..." (PDF). BioWorld 20th Anniversary Edition. 2010.
  3. ↑ Kirsner, Scott (2010). "The Boston area’s top 15 innovators". The Boston Globe.
  4. ↑ Meghna Chakrabarti and Anthony Brooks (October 11, 2010). "Massachusetts Tech Innovators Recognized". WBUR Radio Boston.
  5. ↑ Gambon, Jim (March 15, 2011). "2011 Women to Watch: Daphne Zohar". Boston Business Journal.
  6. ↑ Pogorelc, Deanna (October 9, 2012). "These 12 women are powerful voices both in healthcare innovation and on Twitter". MedCity News.
  7. ↑ Kirsner, Scott (September 15, 2013). "The 10 most influential women in biotech". The Boston Globe.
  8. ↑ Singer-Vine, Jeremy (July 10, 2008). "Big Pharmas Join to Speed Discoveries". The Wall Street Journal.
  9. ↑ McBride, Ryan (June 15, 2009). "Novartis Backing Enlight Biosciences". Xconomy.
  10. ↑ Mack, George S. (2008). "Pharmas partner in venture seeking drug discovery tools". Nature.
  11. ↑ "Enlight Bioscience – Collaborating to Improve the Drug Discovery Process". Merck.
  12. ↑ Zohar, Daphne (August 24, 2009). "Venture Model Makeover & Diet Plan – Step One". Xconomy.

External links

This article is issued from Wikipedia - version of the Monday, May 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.